Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its fluoropyridine structure enhances binding affinity and metabolic stability, making it valuable in optimizing drug candidates for improved efficacy and pharmacokinetics. Commonly employed in the preparation of active pharmaceutical ingredients requiring high enantiomeric purity.